That a large proportion of the enriched pathways observed in French bulldogs were immune-related suggests that French bulldog HGO results in a breed-specific tumor-immune interaction that may impact outcomes in dogs receiving immunotherapy. This evidence concerns the gene HGD and neoplasm.